scholarly article | Q13442814 |
P819 | ADS bibcode | 2014PLoSO...984964D |
P356 | DOI | 10.1371/JOURNAL.PONE.0084964 |
P932 | PMC publication ID | 3906007 |
P698 | PubMed publication ID | 24489654 |
P5875 | ResearchGate publication ID | 260062938 |
P50 | author | Nicolas Sluis-Cremer | Q113121065 |
Michele D Sobolewski | Q122973343 | ||
P2093 | author name string | John W Mellors | |
Deborah McMahon | |||
Geneviève Doyon | |||
Kelly Huber | |||
P2860 | cites work | In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. | Q52050894 |
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. | Q53437454 | ||
The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4 | Q69518980 | ||
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid | Q24596282 | ||
Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells | Q24644201 | ||
ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia | Q28469175 | ||
Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 | ||
HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription | Q30835037 | ||
Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection | Q33476165 | ||
Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone | Q33847737 | ||
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy | Q34290545 | ||
Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency | Q34362915 | ||
Disulfiram reactivates latent HIV-1 in a Bcl-2-transduced primary CD4+ T cell model without inducing global T cell activation | Q35077057 | ||
Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization | Q35589022 | ||
Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy | Q36379282 | ||
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation | Q36409885 | ||
Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals. | Q36831526 | ||
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma | Q36891848 | ||
Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study | Q37115594 | ||
The challenge of finding a cure for HIV infection | Q37407598 | ||
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies | Q37644561 | ||
Structural basis for activation and inhibition of class I phosphoinositide 3-kinases | Q37947094 | ||
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells | Q42770444 | ||
Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone | Q42813546 | ||
Prevalence and predictive value of intermittent viremia with combination hiv therapy | Q43670221 | ||
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine | Q45300837 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e84964 | |
P577 | publication date | 2014-01-29 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Discovery of a small molecule agonist of phosphatidylinositol 3-kinase p110α that reactivates latent HIV-1. | |
P478 | volume | 9 |
Q35195281 | A high throughput RNAi screen reveals determinants of HIV-1 activity in host kinases |
Q59359728 | CD4 T Cell Subsets and Pathways to HIV Latency |
Q90683506 | Diversity of small molecule HIV-1 latency reversing agents identified in low- and high-throughput small molecule screens |
Q33936233 | Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats. |
Q26747110 | Glucose Metabolism in T Cells and Monocytes: New Perspectives in HIV Pathogenesis |
Q56962083 | Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products |
Q57050517 | Mesenchymal stem cells are attracted to latent HIV-1-infected cells and enable virus reactivation via a non-canonical PI3K-NFκB signaling pathway |
Q92300043 | Strategies to eradicate HIV from infected patients: elimination of latent provirus reservoirs |
Q37113972 | The role of Fc receptors in HIV prevention and therapy |
Search more.